instarr.in
Log In

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good

$ 14.00

4.5 (341) In stock

The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma

A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls

Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis

Non-coding RNAs as liquid biopsy biomarkers in cancer

IJMS, Free Full-Text

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment - ScienceDirect

Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation, Molecular Cancer

Related products

Cancer Trends: How Has the COVID-19 Pandemic Affected Cancer

Research Areas: Cancer Diagnosis - NCI

Early Detection Is Key To Effectively Treating Skin Cancers

Early Detection Is Key To Effectively Treating Skin Cancers - Dermatology Physicians of Connecticut

Hundreds Were Mistakenly Told They Might Have Cancer, Test Company Says - The New York Times